Table of contents
Volume 95, Issue 10
Published online 14 November 2006 (1309-1454)
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letter to the Editor
Clinical Studies
Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study FREE
K B Pittman, I N Olver, B Koczwara, D Kotasek, W K Patterson, D M Keefe, C S Karapetis, F X Parnis, S Moldovan, S J Yeend and T J Price for the Adelaide Cancer Trials and Education Collaborative (ACTEC)
Br J Cancer 95: 1309-1313; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603440
Ovarian cancer in younger vs older women: a population-based analysis FREE
J K Chan, R Urban, M K Cheung, K Osann, A Husain, N N Teng, D S Kapp, J S Berek and G S Leiserowitz
Br J Cancer 95: 1314-1320; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603457
The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical records FREE
S Stapley, T J Peters, D Sharp and W Hamilton
Br J Cancer 95: 1321-1325; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603439
Incidence and prognostic value of tumour cells detected by RT–PCR in peripheral blood stem cell collections from patients with Ewing tumour FREE
J Vermeulen, S Ballet, O Oberlin, M Peter, G Pierron, E Longavenne, V Laurence, J Kanold, P Chastagner, O Lejars, J-Y Blay, P Marec-Berard, J Michon, O Delattre and G Schleiermacher
Br J Cancer 95: 1326-1333; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603438
Molecular subtypes of breast cancer and amplification of topoisomerase II
: predictive role in dose intensive adjuvant chemotherapy FREE
J Hannemann, P Kristel, H van Tinteren, M Bontenbal, Q G C M van Hoesel, W M Smit, M A Nooij, E E Voest, E van der Wall, P Hupperets, E G E de Vries, S Rodenhuis and M J van de Vijver
Br J Cancer 95: 1334-1341; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603449
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies FREE
S Leyvraz, R Herrmann, L Guillou, H P Honegger, A Christinat, M F Fey, C Sessa, M Wernli, T Cerny, D Dietrich and B Pestalozzi for the Swiss Group for Clinical Cancer Research (SAKK)
Br J Cancer 95: 1342-1347; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603420
Translational Therapeutics
Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations FREE
J Bodo, L Hunakova, P Kvasnicka, J Jakubikova, J Duraj, J Kasparkova and J Sedlak
Br J Cancer 95: 1348-1353; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603434
A third-generation bisphosphonate, minodronic acid (YM529), successfully prevented the growth of bladder cancer in vitro and in vivo FREE
K Sato, T Yuasa, M Nogawa, S Kimura, H Segawa, A Yokota and T Maekawa
Br J Cancer 95: 1354-1361; advance online publication, October 17, 2006; doi:10.1038/sj.bjc.6603423
Molecular Diagnostics
Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer FREE
G G Van den Eynden, I Van der Auwera, S J Van Laere, V Huygelen, C G Colpaert, P van Dam, L Y Dirix, P B Vermeulen and E A Van Marck
Br J Cancer 95: 1362-1366; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603443
Desmocollin switching in colorectal cancer FREE
K Khan, R Hardy, A Haq, O Ogunbiyi, D Morton and M Chidgey
Br J Cancer 95: 1367-1370; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603453
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis FREE
H-C Zheng, H Takahashi, Y Murai, Z-G Cui, K Nomoto, S Miwa, K Tsuneyama and Y Takano
Br J Cancer 95: 1371-1378; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603425
Preclinical and post-treatment changes in the HCC-associated serum proteome FREE
D G Ward, Y Cheng, G N'Kontchou, T T Thar, N Barget, W Wei, A Martin, M Beaugrand and P J Johnson
Br J Cancer 95: 1379-1383; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603429
Human papillomaviral load changes in low-grade squamous intraepithelial lesions of the uterine cervix FREE
C-M Ho, W-F Cheng, T-Y Chu, C-A Chen, M-H Chuang, S-F Chang and C-Y Hsieh
Br J Cancer 95: 1384-1389; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603430
EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib FREE
H Kimura, Y Fujiwara, T Sone, H Kunitoh, T Tamura, K Kasahara and K Nishio
Br J Cancer 95: 1390-1395; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603428
Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer FREE
B S M S Siriwardena, Y Kudo, I Ogawa, M Kitagawa, S Kitajima, H Hatano, W M Tilakaratne, M Miyauchi and T Takata
Br J Cancer 95: 1396-1403; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603431
A positive role for PEA3 in HER2-mediated breast tumour progression FREE
E Myers, A D K Hill, G Kelly, E W McDermott, N J O'Higgins and L S Young
Br J Cancer 95: 1404-1409; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603427
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity FREE
G R Wilson, A Cramer, A Welman, F Knox, R Swindell, H Kawakatsu, R B Clarke, C Dive and N J Bundred
Br J Cancer 95: 1410-1414; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603444
Genetics and Genomics
Are microRNAs located in genomic regions associated with cancer? FREE
P Lamy, C L Andersen, L Dyrskjøt, N Tørring, T Ørntoft and C Wiuf
Br J Cancer 95: 1415-1418; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603381
Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer FREE
C Rimkus, M Martini, J Friederichs, R Rosenberg, D Doll, J R Siewert, B Holzmann and K P Janssen
Br J Cancer 95: 1419-1423; advance online publication, October 31, 2006; doi:10.1038/sj.bjc.6603452
Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms FREE
C Walker, B Haylock, D Husband, K A Joyce, D Fildes, M D Jenkinson, T Smith, J Broome, K Kopitzki, D G du Plessis, J Prosser, S Vinjamuri and P C Warnke
Br J Cancer 95: 1424-1431; advance online publication, October 10, 2006; doi:10.1038/sj.bjc.6603390
11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours FREE
C C R Ragin, E Taioli, J L Weissfeld, J S White, K M Rossie, F Modugno and S M Gollin
Br J Cancer 95: 1432-1438; advance online publication, September 26, 2006; doi:10.1038/sj.bjc.6603394
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q FREE
B Orsetti, M Nugoli, N Cervera, L Lasorsa, P Chuchana, C Rougé, L Ursule, C Nguyen, F Bibeau, C Rodriguez and C Theillet
Br J Cancer 95: 1439-1447; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603433
A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services FREE
S Peacock, C Apicella, L Andrews, K Tucker, A Bankier, M B Daly and J L Hopper
Br J Cancer 95: 1448-1453; doi:10.1038/sj.bjc.6603451
Letter to the Editor
The evaluation of left ventricular function for patients being considered for, or receiving Trastuzumab (Herceptin) therapy FREE
K F Fox
Br J Cancer 95: 1454; advance online publication, October 24, 2006; doi:10.1038/sj.bjc.6603340
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
